UnannouncedVCInvestor

Column

Startup rounds since 2012 with a Column investor on the board, and the firm's own fund filings.

Raises
39
since 2012
Unannounced
0
no announcement found, of those filed since 2025
Funds
10
fund filings under the firm's name

Rounds

  1. NGM Bio Holdings, Inc.$142MAnnounced27 Mar 2026 · South San Francisco, CA
  2. Neurona Therapeutics, Inc$102MUnclear4 Apr 2025 · South San Francisco, CA
  3. Site Tx, Inc.$6MFiled before 202510 Apr 2024 · San Francisco, CA
  4. Neurona Therapeutics, Inc$120MFiled before 202513 Feb 2024 · South San Francisco, CA
  5. Carmot Therapeutics Inc.$150MFiled before 20256 Jun 2023 · Berkeley, CA
  6. Neurona Therapeutics, Inc$72MFiled before 202523 Dec 2022 · South San Francisco, CA
  7. A2 Biotherapeutics, Inc.$71.6MFiled before 202516 Dec 2022 · Agoura Hills, CA
  8. Hexagon Bio Inc.$67.3MFiled before 202511 Oct 2022 · Menlo Park, CA
  9. Carmot Therapeutics Inc.$161MFiled before 20258 Aug 2022 · Berkeley, CA
  10. Hexagon Bio Inc.$61MFiled before 202519 Jul 2021 · Menlo Park, CA
  11. A2 Biotherapeutics, Inc.$71.5MFiled before 202526 Oct 2020 · Agoura Hills, CA
  12. Carmot Therapeutics Inc.$26.3MFiled before 20251 Oct 2020 · Berkeley, CA
  13. Surrozen, Inc.$50MFiled before 202523 Jun 2020 · South San Francisco, CA
  14. Circle Pharma, Inc.$15MFiled before 202523 Mar 2020 · South San Francisco, CA
  15. RAPT Therapeutics, Inc.$37.1MFiled before 202520 Jun 2019 · South San Francisco, CA
  16. Effector Therapeutics, Inc.$20.4MFiled before 202514 May 2019 · San Diego, CA
  17. Exonics Therapeutics, Inc.$22MFiled before 202520 Nov 2018 · Watertown, MA
  18. Constellation Pharmaceuticals Inc$99MFiled before 20256 Apr 2018 · Cambridge, MA
  19. FLX Bio, Inc.$29.9MFiled before 20254 Jan 2018 · South San Francisco, CA
  20. Carmot Therapeutics Inc.$10.8MFiled before 202525 Aug 2017 · San Francisco, CA
  21. Effector Therapeutics, Inc.$16.8MFiled before 202527 Jul 2017 · San Diego, CA
  22. Neurona Therapeutics Inc$28.7MFiled before 202528 Dec 2016 · South San Francisco, CA
  23. Kallyope, Inc.$28.1MFiled before 202527 Oct 2016 · New York, NY
  24. Constellation Pharmaceuticals Inc$24.3MFiled before 202527 Sep 2016 · Cambridge, MA
  25. FLX Bio, Inc.$50MFiled before 20255 May 2016 · South San Francisco, CA
  26. Constellation Pharmaceuticals Inc$55.8MFiled before 202515 Dec 2015 · Cambridge, MA
  27. Igenica Biotherapeutics, Inc$2.25MFiled before 202514 Oct 2015 · Burlingame, CA
  28. Nurix, Inc.$17MFiled before 202518 Sep 2015 · San Francisco, CA
  29. Igenica Biotherapeutics, Inc$1.23MFiled before 20259 Jun 2015 · Burlingame, CA
  30. Ngm Biopharmaceuticals Inc$106MFiled before 202525 Mar 2015 · South San Francisco, CA
  31. Ngm Biopharmaceuticals Inc$20.7MFiled before 202524 Feb 2015 · South San Francisco, CA
  32. Igenica Biotherapeutics, Inc$5.05MFiled before 202526 Jan 2015 · Burlingame, CA
  33. Constellation Pharmaceuticals Inc$5MFiled before 20255 Aug 2014 · Cambridge, MA
  34. Immune Design Corp.$17.5KFiled before 202512 Jun 2014 · Seattle, WA
  35. Immune Design Corp.$10Filed before 202511 Jun 2014 · Seattle, WA
  36. Immune Design Corp.$10.5KFiled before 202511 Jun 2014 · Seattle, WA
  37. Igenica Inc$7.03MFiled before 20257 Feb 2014 · Burlingame, CA
  38. Nurix, Inc.$2.08MFiled before 20252 Jan 2014 · San Francisco, CA
  39. Aragon Pharmaceuticals, Inc.$37.7MFiled before 20257 Mar 2012 · San Diego, CA

By year

YearRaisesUnannounced
202610
202510
20242—
20231—
20224—
20211—
20204—
20192—
20183—
20172—
20164—
20157—
20146—
20121—

Raises are checked for an announcement from 2025 on.

Funds

The firm's own fund filings, each at its latest filing.

FundFiledSizeRaised
Column Group VI, LP16 Dec 2025$600M—
Column Group Opportunity IV, LP16 Dec 2025$600M—
Column Group SPV I, LP8 Dec 2022$10.5M$10.5M
Column Group V, LP16 Jun 2022$600M$600M
Column Group Opportunity III, LP16 Jun 2022$600M$600M
Column Group IV, LP11 Dec 2019$700M—
Column Group IV-A, LP11 Dec 2019$25M—
Column Group III, LP27 Apr 2016$240M$240M
Column Group Iii-a, LP27 Apr 2016$271M$271M
Column Group II, LP16 Sep 2014$306M$306M

Listed because a Column fund's filing names a director of each company. A name match is not a verified identity.